Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Common Equity (2020 - 2025)

LifeStance Health (LFST) has disclosed Common Equity for 6 consecutive years, with $1.5 billion as the latest value for Q4 2025.

  • On a quarterly basis, Common Equity rose 5.17% to $1.5 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $1.5 billion, a 5.17% increase, with the full-year FY2025 number at $1.5 billion, up 5.17% from a year prior.
  • Common Equity was $1.5 billion for Q4 2025 at LifeStance Health, up from $1.5 billion in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $1.5 billion in Q4 2021 to a low of $954.0 million in Q1 2021.
  • A 5-year average of $1.5 billion and a median of $1.5 billion in 2023 define the central range for Common Equity.
  • Peak YoY movement for Common Equity: skyrocketed 61.69% in 2022, then dropped 5.91% in 2023.
  • LifeStance Health's Common Equity stood at $1.5 billion in 2021, then dropped by 1.7% to $1.5 billion in 2022, then fell by 5.91% to $1.4 billion in 2023, then grew by 1.21% to $1.4 billion in 2024, then grew by 5.17% to $1.5 billion in 2025.
  • Per Business Quant, the three most recent readings for LFST's Common Equity are $1.5 billion (Q4 2025), $1.5 billion (Q3 2025), and $1.5 billion (Q2 2025).